Literature DB >> 15848495

Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease.

J Rozanski1, I Kozlowska, M Myslak, L Domanski, J Sienko, K Ciechanowski, M Ostrowski.   

Abstract

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease and a frequent cause of end-stage renal failure. Transplantation in patients with ADPKD is associated with specific cyst-related problems, especially urinary tract infections (UTI). Although pretransplant nephrectomy has been applied in this group of patients, evidence of the benefits of this strategy is lacking. Therefore, we compared the outcomes and posttransplant complications among patients with or without pretransplant nephrectomy. PATIENTS AND METHODS: ADPKD patients (73) transplanted from cadaveric donors were reviewed retrospectively with regard to posttransplant complications and outcomes. The groups either underwent pretransplant unilateral nephrectomy (n = 30) or were transplanted with native kidneys intact (n = 43).
RESULTS: Two patients underwent simultaneous bilateral nephrectomy due to a large size of the polycystic kidneys interfering with the transplant operation. Overall postransplant complications were more frequent in the group without nephrectomy (34% vs 20%); however, the difference was not statistically significant. Most complications were related to cyst infections with 3 deaths (12%) due to lethal septicemia in the group without nephrectomy. No infection-related deaths were noted in the group with pretransplant nephrectomy.
CONCLUSIONS: Graft and patient outcomes as well postransplant complications were similar in both groups, independent of previous nephrectomy. It seems that pretransplant unilateral nephrectomy should not be routine and has no advantage over transplantation with both native kidneys intact, although this conclusion is limited by the small number of patients. An Individualized approach should be applied especially when there has been a history of cyst-related infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848495     DOI: 10.1016/j.transproceed.2004.12.115

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  15 in total

1.  Volume regression of native polycystic kidneys after renal transplantation.

Authors:  Yeonsoon Jung; María V Irazabal; Fouad T Chebib; Peter C Harris; Patrick G Dean; Mikel Prieto; Fernando G Cosio; Ziad M El-Zoghby; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2015-06-04       Impact factor: 5.992

2.  Laparoscopic pretransplant nephrectomy with morcellation in autosomic-dominant polycystic kidney disease patients with end-stage renal disease.

Authors:  Anastasios D Asimakopoulos; Richard Gaston; Roberto Miano; Filippo Annino; Camille Mugnier; Lorenzo Dutto; Giuseppe Vespasiani; Enrico Spera; Jean-Luc Hoepffner; Thierry Piechaud
Journal:  Surg Endosc       Date:  2014-08-15       Impact factor: 4.584

3.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

4.  Recurrent urinary tract infections in kidney transplant recipients.

Authors:  Subhashis Mitra; George John Alangaden
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

Review 5.  Tailoring the 'Perfect Fit' for Renal Transplant Recipients with End-stage Polycystic Kidney Disease: Indications and Timing of Native Nephrectomy.

Authors:  Chrysoula Argyrou; Demetrios Moris; Spyridon Vernadakis
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

6.  Live Donor Renal Transplant With Simultaneous Bilateral Nephrectomy for Autosomal Dominant Polycystic Kidney Disease Is Feasible and Satisfactory at Long-term Follow-up.

Authors:  Sarwat B Ahmad; Brian Inouye; Michael S Phelan; Andrew C Kramer; Jay Sulek; Matthew R Weir; Rolf N Barth; John C LaMattina; Eugene J Schweitzer; David B Leeser; Silke V Niederhaus; Stephen T Bartlett; Jonathan S Bromberg
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

7.  Incidental renal cell carcinoma presenting in a renal transplant recipient with autosomal dominant polycystic kidney disease: a case report.

Authors:  Toshihiro Misumi; Kentaro Ide; Takashi Onoe; Masataka Banshodani; Hirofumi Tazawa; Yoshifumi Teraoka; Ryuichi Hotta; Masahiro Yamashita; Hirotaka Tashiro; Hideki Ohdan
Journal:  J Med Case Rep       Date:  2012-06-13

8.  Giant polycystic kidney and acute abdomen in chronic renal failure.

Authors:  Pedro F Ferraz Arruda; Luis Cesar F Spessoto; Moacir Fernandes Godoy; José Maria Pereira de Godoy
Journal:  Urol Ann       Date:  2011-01

9.  Stratified Cox models with time-varying effects for national kidney transplant patients: A new blockwise steepest ascent method.

Authors:  Kevin He; Ji Zhu; Jian Kang; Yi Li
Journal:  Biometrics       Date:  2021-05-04       Impact factor: 1.701

10.  Transperitoneal laparoscopic nephrectomy for autosomal dominant polycystic kidney disease.

Authors:  Grégory Verhoest; Arnaud Delreux; Romain Mathieu; Jean-Jacques Patard; Cécile Vigneau; Nathalie Rioux-Leclercq; Karim Bensalah
Journal:  JSLS       Date:  2012 Jul-Sep       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.